A- Primary links
- About USP
- Overview
- Leadership
- Governance
- Executive Team
- Roger L. Williams
- Susan de Mars
- Brian Hendrix
- Scott Henderson
- V. Srini Srinivasan
- Angela Long
- Ed Zhao
- Ken Alexander
- Susan Bach
- Todd Cecil
- Ranjan Chakrabarti
- Nelson dos Santos
- Shawn Dressman
- Hermes van der Lee
- Linda M. Guard
- Kevin Hool
- John Hu
- Drew Lutz
- Patrick Lukulay
- Reema Jweied-Guegel
- Tina Morris
- K.V. Surendra Nath
- Gabriel Giancaspro
- James Thompson
- Matthew Van Hook
- Richard Wailes
- Karen C. Bruntrager
- Christine Feaster
- Sameer Navalgund
- Articles of Incorporation
- Bylaws
- Policies & Rules
- Our Impact
- Mission & History
- Statements on USP Standards
- Statement on Public Standards
- Statement on Scope
- Statement on Governance and Processes
- Statement on Science
- Statement on Reference Materials
- Statement on Modernization
- Statement on Market Access
- Statement on Harmonization
- Statement on Globalization and Partnering
- Statement on Public Standards for Compounding
- Value of Standards
- Global Presence
- Quality Policy & ISO Accreditation
- Our Vision
- Legal Recognition
- Press Room
- Careers
- USP–NF
- Overview
- Official Text
- Revision Bulletins
- <2040> Disintegration and Dissolution of Dietary Supplements, Dissolution Section
- Verapamil Hydrochloride Extended-Release Tablets
- <2040> Disintegration and Dissolution of Dietary Supplements, Dissolution Section
- <232> Elemental Impurities—Limits and <233> Elemental Impurities—Procedures
- Docetaxel
- Insulin
- Tacrolimus Capsules
- Divalproex Sodium Extended-Release Tablets
- Valacyclovir Tablets
- Metoprolol Succinate Extended-Release Tablets
- Levetiracetam Oral Solution
- Mycophenolate Mofetil Capsules
- Docetaxel Injection
- Budesonide
- Cetirizine Hydrochloride Tablets
- Sucrose
- Meloxicam
- Oxcarbazepine Oral Suspension
- Divalproex Sodium Extended-Release Tablets
- Losartan Potassium
- Losartan Potassium Tablets
- Imiquimod
- Nitrofurantoin Capsules
- Pramipexole Dihydrochloride
- Cilostazol Tablets
- Clarithromycin Tablets
- Famciclovir
- Indomethacin Extended Release Capsules
- Venlafaxine Hydrochloride Extended-Release Capsules
- Tacrolimus
- Alprazolam Orally Disintegrating Tablets
- Fentanyl: Postponement
- Isosorbide Mononitrate Extended-Release Tablets
- Cetirizine Hydrochloride Tablets
- Alfuzosin Hydrochloride Extended-Release Tablets
- Calcitonin Salmon
- Gadodiamide Injection
- Esmolol Hydrochloride
- Tobramycin Inhalation Solution
- Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets
- Levetiracetam Tablets
- <788> Particulate Matter in Injections
- Adapalene
- Beta Carotene
- Beta Carotene Capsules
- Beta Carotene Preparation
- Citalopram Hydrobromide
- Doxycycline Hyclate Delayed-Release Tablets
- Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets
- Gelatin
- Isophane Insulin Human Suspension
- Isophane Insulin Suspension
- Isotretinoin Capsules
- Metformin Hydrochloride Extended–Release Tablets
- Modafinil Tablets
- Morphine Sulfate Injection
- Olanzapine
- Olanzapine Tablets
- Oxaliplatin Injection
- Primaquine Phosphate
- Selenious Acid Injection
- Venlafaxine Hydrochloride Extended-Release Capsules
- Vitamin A Oral Liquid Preparation
- Ziprasidone Hydrochloride
- Mometasone Furoate Topical Solution
- Mycophenolate Mofetil Tablets
- Polysorbate 80
- Ribavirin Tablets 2
- Sertraline Tablets
- Sumatriptan Tablets
- Talc
- IRAs
- Errata
- Accelerated Revision Process
- Accelerated Revision History
- <232> Elemental Impurities—Limits and <233> Elemental Impurities—Procedures
- <701> Disintegration
- Promethazine Hydrochloride Tablets
- Zolpidem Tartrate Extended-Release Tablets
- <701> Disintegration
- Diltiazem Hydrochloride Extended-Release Capsules
- Metolazone Tablets
- Olopatadine Hydrochloride Ophthalmic Solution
- Alprazolam Extended-Release Tablets
- Carbidopa
- Divalproex Sodium Delayed-Release Capsules
- Ginkgo
- <1053> Biotechnology-Derived Articles—Capillary Electrophoresis
- Doxycycline Hyclate Delayed-Release Tablets
- General Chapter <711> Dissolution
- Primaquine Phosphate
- <2040> Disintegration and Dissolution of Dietary Supplements, Dissolution Section
- <2040> Disintegration and Dissolution of Dietary Supplements
- Acetaminophen and Tramadol Hydrochloride Tablets
- Powdered Ginkgo Extract
- Ginkgo Capsules
- Alfuzosin Hydrochloride
- Amlodipine Besylate Tablets
- Budesonide
- Amoxicillin and Clavulanate Potassium for Oral Suspension
- Enoxaparin Sodium and Enoxaparin Sodium Injection
- Acetazolamide Oral Suspension Monograph
- Lamivudine
- Lithium Hydroxide
- Ademetionine Disulfate Tosylate
- Bupropion Hydrochloride Extended-Release Tablets
- Alendronic Acid Tablets
- Calcitonin Salmon Injection
- Primidone Tablets
- Amoxicillin and Clavulanate Potassium Tablets
- Galantamine Tablets
- Carvedilol
- Anticoagulant Heparin Solution, Antithrombin III Human, Heparin Calcium, Heparin Calcium Injection...
- Carvedilol Tablets
- Calcitonin Salmon
- Sertraline Tablets
- Zaleplon
- Azithromycin Tablets
- Cefazolin Sodium
- Gadodiamide Injection
- Calcitonin Salmon Nasal Solution
- Cefdinir
- Calcium Silicate Monograph (First Supplement to USP 30–NF 25, page 3740)
- Capecitabine Tablets
- General Chapter <788> Particulate Matter in Injections: Postponement
- Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules
- Cetirizine Hydrochloride Oral Solution
- Cefdinir
- Cetirizine Hydrochloride
- Cetirizine Hydrochloride Oral Solution
- Clonidine Transdermal System
- Cilostazol Tablets
- Hydromorphone Hydrochloride Oral Solution
- Clidinium Bromide
- Deferoxamine Mesylate
- Clarithromycin Tablets
- Divalproex Sodium Delayed–Release Capsules
- Delayed Implementation for General Chapter <467> Residual Solvents
- Divalproex Sodium Extended–Release Tablets
- Diclofenac Sodium Extended-Release Tablets
- Donepezil Hydrochloride
- Diclofenac Sodium Extended-Release Tablets
- Doxycycline Hyclate Delayed–Release Tablets
- Donepezil Hydrochloride Tablets
- Doxycycline Hyclate Delayed-Release Tablets
- Doxycycline Hyclate Tablets
- Estradiol Transdermal System
- Enoxaparin Sodium and Enoxaparin Sodium Injection
- Enoxaparin Sodium and Enoxaparin Sodium Injection
- Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets
- Enoxaparin Sodium Monograph
- Fluconazole Tablets
- Errata to <467> Organic Volatile Impurities Section in USP Monographs Revised in Supplement 1
- Fluticasone Propionate Nasal Spray
- Erratum to <788> Particulate Matter in Injections and the USP Particle Count Reference Standard
- Erratum to Mannitol Injection Monograph
- Estradiol Vaginal Inserts
- Ethinyl Estradiol Tablets
- Ginkgo Tablets
- Glimepiride Tablets
- General Chapter <1>
- Glyburide Tablets
- General Chapter <467> Residual Solvents / Organic Volatile Impurities
- Helium, Nitrous Oxide, Nitrogen, and Nitrogen 97 Percent Monographs
- Extended Phenytoin Sodium Capsules
- Hydrochlorothiazide Capsules
- Felodipine Extended-Release Tablets
- Iodixanol Injection
- Fenofibrate Capsules
- Iohexol Injection
- Fexofenadine Hydrochloride and Fexofenadine Hydrochloride Capsules
- Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets
- Ivermectin Paste
- Telmisartan Tablets
- Fexofenadine Hydrochloride Tablets
- Lamotrigine Tablets
- Fluvoxamine Maleate Tablets
- Letrozole Tablets
- Irinotecan Hydrochloride
- Fosinopril Sodium and Hydrochlorothiazide Tablets—Revision to Related Compounds Test
- Levetiracetam Tablets
- Gabapentin Tablets
- Levofloxacin
- Galantamine Hydrobromide Monograph
- Lamivudine and Zidovudine Tablets
- Galantamine Tablets
- Clonidine Transdermal System
- General Chapter <1> Injections Labeling on Ferrules and Cap Overseals Section
- General Chapter <381> Elastomeric Closures for Injections
- Losartan Potassium Tablets
- General Chapter <467> Organic Volatile Impurities/Residual Solvents—Implementation Date Delayed to J
- <2040> Disintegration and Dissolution of Dietary Supplements, Dissolution Section
- Etodolac Extended-Release Tablets
- Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets
- General Chapter <1066>
- General Chapter <2040> Disintegration and Dissolution of Dietary Supplements—Official Date Delayed for Dissolution Requirements
- General Chapter <2040> Disintegration and Dissolution of Dietary Supplements—Official Date Delayed for Dissolution Requirements
- General Chapter <621> Chromatography - System Suitability
- General Chapter <621> Chromatography - System Suitability
- General Chapter <671>Containers—Performance Testing
- General Chapter <788> Particulate Matter in Injections
- General Chapter Heavy Metals 823 Method II
- Glipizide and Metformin Hydrochloride Tablets
- Glycerin Monograph
- Harmonized Microbiology General Chapters
- Irinotecan Hydrochloride
- Isotretinoin Capsules
- Ivermectin Tablets
- Leflunomide Tablets
- Levalbuterol Hydrochloride
- Levetiracetam
- Levothyroxine Sodium
- Levothyroxine Sodium Tablets
- Lidocaine and Prilocaine Cream Errata
- Lidocaine and Prilocaine Cream—Revision to Related Compounds Test
- Loratadine Oral Solution
- Lycopene Preparation
- Lycopene Preparation
- Maltitol Solution
- Mefloquine Hydrochloride
- Mefloquine Hydrochloride Tablets
- Mercaptopurine Tablets
- Metformin Hydrochloride Extended-Release Tablets
- Metformin Hydrochloride Extended-Release Tablets
- Metformin Hydrochloride Extended-Release Tablets
- Methotrexate
- Midazolam
- Midazolam Injection
- Mometasone Furoate Cream
- Mometasone Furoate Ointment
- Mycophenolate Mofetil Capsules
- Mycophenolate Mofetil Tablets
- Nateglinide
- Nifedipine Extended-Release Tablets
- Nifedipine Extended-Release Tablets
- Noncrystallizing Sorbitol Solution
- Noncrystallizing Sorbitol Solution
- Norgestimate and Ethinyl Estradiol Tablets Monograph
- Notice of Correction to Ranitidine Injection
- Notice of Harmonized Text: USP–NF General Chapter <788> Particulate Matter in Injections
- Ondansetron Orally Disintegrating Tablets
- Ondansetron Tablets
- Ondansetron Tablets
- Ondansetron Tablets
- Ondansetron Tablets
- Oseltamivir Phosphate Capsules
- Oxaliplatin for Injection
- Oxybutynin Chloride Extended-Release Tablets
- Oxybutynin Chloride Tablets
- Oxycodone Hydrochloride
- Pantoprazole Sodium Delayed-Release Tablets
- Pilocarpine Hydrochloride Tablets
- Piperacillin and Tazobactam for Injection
- Powdered Ginkgo Extract
- Propofol Injectable Emulsion
- Propranolol Hydrochloride Extended-Release Capsules
- Propylene Glycol
- Propylene Glycol
- Protamine Sulfate
- Reserpine Tablets
- Residual Solvents: General Notices and General Chapter <467>—Implementation Date Delayed
- Revision Bulletin: Cilostazol Tablets
- Revision Bulletin: Heparin Sodium and Heparin Calcium Monographs
- Revision Bulletin: Oxaliplatin
- Revision Bulletin: Oxybutynin Chloride Extended–Release Tablets
- Revision Bulletin: Ribavirin Tablets
- Revision Bulletin: Ribavirin Tablets
- Rocuronium Bromide
- Sertraline Tablets
- Sodium Chloride Monograph
- Sorbitol Solution
- Sorbitol Solution
- Sorbitol Sorbitan Solution
- Sumatriptan Tablets 2
- Tamsulosin Hydrochloride Capsules 1
- Tamsulosin Hydrochloride Capsules
- Tamsulosin Hydrochloride Capsules
- Tazobactam
- Terbinafine Hydrochloride
- Tetracycline Hydrochloride Capsules
- Tomato Extract Containing Lycopene
- Topiramate Tablets
- Triamcinolone Hexacetonide
- USP ISSUES IMMEDIATE INTERIM REVISION ANNOUNCEMENT FOR GENERAL CHAPTER <467> RESIDUAL
- USP Postpones the Official Date of the Glycerin Monograph: Revisions and Clarifications to be Made
- USP/PDA Residual Solvents Educational Conference
- Valacyclovir Hydrochloride
- Vasopressin
- Vasopressin
- Verapamil Hydrochloride Extended-Release Tablets
- Vinblastine Sulfate
- Vinblastine Sulfate for Injection
- Vincristine Sulfate
- Vincristine Sulfate Injection
- Vincristine Sulfate for Injection
- Vitamin A Oral Liquid Preparation
- Zolpidem Tartrate Extended–Release Tablets
- Zolpidem Tartrate Tablets
- Accelerated Revision History
- Stage 6
- <267> Porosimetry by Mercury Intrusion
- Wheat Starch
- <711> Dissolution
- <811> Powder Fineness
- <905> Uniformity of Dosage Units
- Anhydrous Lactose
- Crospovidone
- Magnesium Stearate
- <85> Bacterial Endotoxins Test
- Povidone
- Benzyl Alcohol
- Stearic Acid
- Sucrose
- <696> Crystallinity Determination by Solution Calorimetry
- Cellacefate
- <616> Bulk and Tapped Density
- Potato Starch
- Anhydrous Citric Acid
- Butylparaben
- Citric Acid Monohydrate
- Ethylcellulose
- Lactose Monohydrate
- Proposal Status/Commentary
- Revision Bulletins
- Pharmacopeial Forum
- Key Issues
- Development Process
- Notices
- Harmonization
- Pending Monographs
- Dietary Supplements
- Food Ingredients
- Reference Standards
- Around the World
- Meetings & Courses
- Store
B -USP Verified
C -Global Health Impact Programs
C -Members
D -Members BOT
E -Distributors
F -Audiences
G -Regulators
H -Consumers
I -HealthCare Professional
Z -Support
- Support Home
- General Information
- Frequently Asked Questions
- USP and its Standards
- Compliance with the USP–NF
- Standards-Setting Process
- Chromatography
- Reagents, Reference Standards, and Impurities
- Equipment
- Microbiology
- Pending Monographs
- Governance
- Reference Standards
- Food Chemicals Codex (FCC)
- General Chapter <467>—Residual Solvents
- General Chapter <823>
- Heparin
- Pharmacopeial Education
- Total Organic Carbon and Conductivity Testing
- USP Verification Services
- USP–NF USB Flash Drive
Follow Us On: